These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 3609968)

  • 21. Effects of prenatal exposure to methylazoxymethanol (MAM) on brain weight, hypothalamic cell number, pituitary structure, and postnatal growth in the rat.
    Rodier PM; Kates B; White WA; Muhs A
    Teratology; 1991 Mar; 43(3):241-51. PubMed ID: 1673036
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Methylazoxymethanol microencephaly in rats: neurochemical characterization and behavioral studies with the nootropic oxiracetam.
    Banfi S; Dorigotti L; Abbracchio MP; Balduini W; Coen E; Ragusa C; Cattabeni F
    Pharmacol Res Commun; 1984 Jan; 16(1):67-83. PubMed ID: 6701181
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Methylazoxymethanol acetate cortical hypoplasia alters the pattern of stimulation-induced behavior in neonatal rats.
    Moran TH; Sanberg PR; Antuono PG; Coyle JT
    Brain Res; 1986 Jun; 392(1-2):235-42. PubMed ID: 3486698
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Developmental neurotoxicity: evaluation of testing procedures with methylazoxymethanol and methylmercury.
    Goldey ES; O'Callaghan JP; Stanton ME; Barone S; Crofton KM
    Fundam Appl Toxicol; 1994 Oct; 23(3):447-64. PubMed ID: 7835545
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Methylazoxymethanol (MAM)-induced brain lesion and oral dyskinesia in rats.
    Johansson P
    Psychopharmacology (Berl); 1990; 100(1):72-6. PubMed ID: 2296629
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The effect of methylazoxymethanol on growth of the spheno-occipital synchondrosis in rats.
    Melsen B; Moss ML
    Acta Anat (Basel); 1977; 97(3):300-6. PubMed ID: 855632
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Brain changes in rats induced by prenatal injection of methylazoxymethanol.
    Tamaru M; Hirata Y; Nagayoshi M; Matsutani T
    Teratology; 1988 Feb; 37(2):149-57. PubMed ID: 3353865
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Selective ablation of neurons by methylazoxymethanol during pre- and postnatal brain development.
    Chen S; Hillman DE
    Exp Neurol; 1986 Oct; 94(1):103-19. PubMed ID: 3758276
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The prenatal methylazoxymethanol acetate treatment: a neurodevelopmental animal model for schizophrenia?
    Jongen-Rêlo AL; Leng A; Lüber M; Pothuizen HH; Weber L; Feldon J
    Behav Brain Res; 2004 Mar; 149(2):159-81. PubMed ID: 15129780
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Methylazoxymethanol-induced micrencephaly in the brown Norway strain: behavior and brain weight.
    Ferguson SA; Holson RR
    Int J Dev Neurosci; 1997 Feb; 15(1):75-86. PubMed ID: 9099619
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Functional effects of methylazoxymethanol-induced cerebellar hypoplasia in rats.
    Ferguson SA; Paule MG; Holson RR
    Neurotoxicol Teratol; 1996; 18(5):529-37. PubMed ID: 8888017
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Pervasive hyperactivity and long-term learning impairments in rats with induced micrencephaly from prenatal exposure to methylazoxymethanol.
    Vorhees CV; Fernandez K; Dumas RM; Haddad RK
    Brain Res; 1984 Jul; 317(1):1-10. PubMed ID: 6540618
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Neuropharmacological study of aged MAM-treated rats.
    Greiner PO; Charles P; Bonnet M; Angignard D; Dupont JM; Herold M; Borzeix MG
    Neurobiol Aging; 1992; 13(4):527-9. PubMed ID: 1492871
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Bromodeoxyuridine and methylazoxymethanol exposure during brain development affects behavior in rats: consideration for a role of nerve growth factor and brain derived neurotrophic factor.
    Fiore M; Aloe L; Westenbroek C; Amendola T; Antonelli A; Korf J
    Neurosci Lett; 2001 Aug; 309(2):113-6. PubMed ID: 11502358
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Methylazoxymethanol as a developmental model of neurotoxicity.
    Kabat K; Buterbaugh GG; Eccles CU
    Neurobehav Toxicol Teratol; 1985; 7(5):519-25. PubMed ID: 4080069
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Methylazoxymethanol acetate: effect of postnatal injection on brain amines and behavior.
    Lai H; Quock RM; Makous W; Horita A; Jen LS
    Pharmacol Biochem Behav; 1978 Mar; 8(3):251-7. PubMed ID: 652833
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Sleep-waking cycle in microencephalic rats induced by prenatal methylazoxymethanol application.
    Kiyono S; Seo M; Shibagaki M
    Electroencephalogr Clin Neurophysiol; 1980 Jan; 48(1):73-9. PubMed ID: 6153325
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Effects of fetal methylazoxymethanol acetate lesion on the synaptic neurochemistry of the adult rat striatum.
    Beaulieu M; Coyle JT
    J Neurochem; 1981 Oct; 37(4):878-87. PubMed ID: 6119358
    [No Abstract]   [Full Text] [Related]  

  • 39. Fetally-induced noradrenergic hyperinnervation of cerebral cortex results in persistent down-regulation of beta-receptors.
    Beaulieu M; Coyle JT
    Brain Res; 1982 Aug; 256(4):491-4. PubMed ID: 6290000
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Effects of prenatal methylazoxymethanol acetate (MAM) treatment in rats on water maze performance.
    Leng A; Jongen-Rêlo AL; Pothuizen HH; Feldon J
    Behav Brain Res; 2005 Jun; 161(2):291-8. PubMed ID: 15922056
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.